Health
COVID: new antibody treatment could offer up to 18 months’ protection against severe disease – The Conversation UK
AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials.
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial the final stage of testing before a drug is authorised that suggest its new COVID treatment, AZD7442, is effective…
Continue Reading
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
Noosa News11 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland